Terremoto Biosciences
Developing highly targeted, small molecule medicines.
About
Terremoto Biosciences is a biotechnology company redefining small-molecule therapeutics through cutting-edge medicinal chemistry and novel covalency technologies. They engineer next-generation oral medicines designed for superior efficacy and patient outcomes, aiming to set new class standards for targets with historically narrow therapeutic windows. The company seeks to deliver transformative therapies to patients by pursuing "undruggable" targets.
Key facts
At-a-glance profile data
- Website
- terremotobio.com
- Headquarters
- South San Francisco, California, USA
- Employees
- 54
- Total funding
- $108M (Series C)
- Business model
- B2B
- Tags
- BiotechnologyPharmaceuticalsDrug DiscoveryHealthcare
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 15 Apr 2026 | Series C | $108M | - |
Tech stack
Detected on terremotobio.com, last scanned 9 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Cookie consent
- Cookiebot
Frequently asked
How much funding has Terremoto Biosciences raised?
Terremoto Biosciences has raised a total of $108M in funding. The most recent round on record is Series C.
How many employees does Terremoto Biosciences have?
Terremoto Biosciences has approximately 54 people on record.